跳至主要内容
临床试验/ISRCTN13661311
ISRCTN13661311已完成未知

Intranasal fentanyl combined with oral midazolam for pediatric dental sedation: a controlled randomized blinded cross-over clinical trial

King Saud University0 个研究点目标入组 32 人开始时间: 2021年11月23日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
32

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35204863/ Post-discharge effects and parents' opinions (added 15/07/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. 3 - 6 years old
  • 3. Frankl behaviour rating scale 1 or 2
  • 4. Mallampati score I or II
  • 5. Brodsky tonsillar size scoring 0 or 1 or 2
  • 6. Children within the normal range of weight
  • 7. Children who needed two sedation visits for completion of dental treatment
  • 8. Children who needed a comparable dental treatment (as regards restorations, pulp treatment, crowns, extraction) on both sides of the same jaw.

排除标准

  • 1. Children with learning difficulties or mental disabilities
  • 2. Children with active upper respiratory tract infection, any history of a recent cough or cold (less than 2 weeks)
  • 3. Children with a known allergy or hypersensitive reaction to either midazolam or fentanyl
  • 4. Children at risk of airway obstruction
  • 5. Children with any intranasal pathology or congenital anomaly
  • 6. Children with a previous history of moderate sedation

研究者

相似试验